JP2003066028A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2003066028A5 JP2003066028A5 JP2002138264A JP2002138264A JP2003066028A5 JP 2003066028 A5 JP2003066028 A5 JP 2003066028A5 JP 2002138264 A JP2002138264 A JP 2002138264A JP 2002138264 A JP2002138264 A JP 2002138264A JP 2003066028 A5 JP2003066028 A5 JP 2003066028A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- acid sequence
- same
- salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 125000003275 alpha amino acid group Chemical group 0.000 claims 38
- 102000004169 proteins and genes Human genes 0.000 claims 26
- 108090000623 proteins and genes Proteins 0.000 claims 26
- 150000003839 salts Chemical class 0.000 claims 25
- 108090000765 processed proteins & peptides Proteins 0.000 claims 21
- 229920001184 polypeptide Polymers 0.000 claims 12
- 102000004196 processed proteins & peptides Human genes 0.000 claims 12
- 108091033319 polynucleotide Proteins 0.000 claims 10
- 102000040430 polynucleotide Human genes 0.000 claims 10
- 239000002157 polynucleotide Substances 0.000 claims 10
- 238000012216 screening Methods 0.000 claims 10
- 238000000034 method Methods 0.000 claims 9
- 150000001408 amides Chemical class 0.000 claims 8
- 150000002148 esters Chemical class 0.000 claims 8
- 150000001875 compounds Chemical class 0.000 claims 5
- 108091032973 (ribonucleotides)n+m Proteins 0.000 claims 4
- 239000000883 anti-obesity agent Substances 0.000 claims 4
- 229940125710 antiobesity agent Drugs 0.000 claims 4
- 208000008589 Obesity Diseases 0.000 claims 3
- 230000000295 complement effect Effects 0.000 claims 3
- 239000000032 diagnostic agent Substances 0.000 claims 3
- 229940039227 diagnostic agent Drugs 0.000 claims 3
- 235000020824 obesity Nutrition 0.000 claims 3
- 208000022531 anorexia Diseases 0.000 claims 2
- 230000000692 anti-sense effect Effects 0.000 claims 2
- 230000036528 appetite Effects 0.000 claims 2
- 235000019789 appetite Nutrition 0.000 claims 2
- 206010061428 decreased appetite Diseases 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 230000000694 effects Effects 0.000 claims 2
- 239000002773 nucleotide Substances 0.000 claims 2
- 125000003729 nucleotide group Chemical group 0.000 claims 2
- 230000000069 prophylactic effect Effects 0.000 claims 2
- 229940124597 therapeutic agent Drugs 0.000 claims 2
- 102000040650 (ribonucleotides)n+m Human genes 0.000 claims 1
- 102000053642 Catalytic RNA Human genes 0.000 claims 1
- 108090000994 Catalytic RNA Proteins 0.000 claims 1
- 230000003579 anti-obesity Effects 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 230000007423 decrease Effects 0.000 claims 1
- 108091092562 ribozyme Proteins 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2002138264A JP4284034B2 (ja) | 2001-05-15 | 2002-05-14 | スクリーニング方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2001145411 | 2001-05-15 | ||
| JP2001-145411 | 2001-05-15 | ||
| JP2002138264A JP4284034B2 (ja) | 2001-05-15 | 2002-05-14 | スクリーニング方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2003066028A JP2003066028A (ja) | 2003-03-05 |
| JP2003066028A5 true JP2003066028A5 (enExample) | 2005-09-15 |
| JP4284034B2 JP4284034B2 (ja) | 2009-06-24 |
Family
ID=26615135
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002138264A Expired - Fee Related JP4284034B2 (ja) | 2001-05-15 | 2002-05-14 | スクリーニング方法 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP4284034B2 (enExample) |
-
2002
- 2002-05-14 JP JP2002138264A patent/JP4284034B2/ja not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2004000251A5 (enExample) | ||
| JP2004536614A5 (enExample) | ||
| JP2004511201A5 (enExample) | ||
| JP2006149395A5 (enExample) | ||
| MXPA04008077A (es) | Anticuerpos ant-a° y su uso. | |
| JP2000312590A5 (enExample) | ||
| WO2005093080A3 (de) | Nitrilhydratase aus rhodococcus | |
| EP2314604A3 (en) | Nucleic acids coding for adhesion factors of group B streptococcus, adhesion factors of group B streptococcus and further uses thereof | |
| WO2005023992A3 (en) | Compositions and methods for inhibiting white spot syndrome virus (wssv) infection | |
| JP2006158399A5 (ja) | 細胞増殖抑制タンパク質並びにそれを用いる細胞増殖抑制剤、癌診断薬及び癌治療剤 | |
| JP2003066028A5 (enExample) | ||
| JP2003334088A5 (enExample) | ||
| JP2005179268A5 (enExample) | ||
| WO2001053347A3 (fr) | Gene nphs2 implique dans le syndrome nephrotique cortico-resistant, proteine codee par ce gene et utilisations diagnostiques et therapeutiques | |
| DE60132341D1 (de) | Isolierung und sequenzierung vom gen ptsi aus c. glutamicum | |
| JP2003113111A5 (enExample) | ||
| JP2003334089A5 (enExample) | ||
| WO2003031594A3 (en) | Nucleotide and amino acid sequences relating to respiratory diseases and obesity | |
| JP2004073182A5 (enExample) | ||
| WO2003025179A1 (fr) | Nouveau polypeptide, adn associe et utilisation de ce polypeptide | |
| JP2002335976A5 (enExample) | ||
| JPWO2020014588A5 (enExample) | ||
| JP2005514010A5 (enExample) | ||
| JP2004217634A5 (enExample) | ||
| JP2003061662A5 (enExample) |